Oakland Hills Dermatology has been actively enrolling participants in Vitiligo clinical trial. For more information about the trials and whether you or your patients may qualify, please contact Oakland Hills Dermatology Clinical Research Department at (248) 858-2255 or via email: info@oaklandhillsdermatology.com

Study ID: M19-044 study

Study Title: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy

Sponsor: Abbvie

Eligibility Criteria:

  • Adult and adolescent individuals must be ≥ 12 years of age
  • Body weight must be ≥ 30 kg for subjects who are ≥ 12 and < 18 years of age.
  • Documented clinical diagnosis of Non-Segmental Vitiligo

Contact: Oakland Hills Dermatology Clinical Research Department
Phone # 248 858 2255
Email: info@oaklandhillsdermatology.com